Cargando…

Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study

Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease that is associated with high serum uric acid (SUA) levels, although the effects of high SUA levels on NAFLD remission remain unclear. In addition, it is unclear whether obesity and high SUA levels have a combined effect on NAFLD re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chao, Yang, Shujuan, Feng, Chunhong, Zhang, Chuan, Xu, Weiwei, Zhang, Liyun, Yan, Yixin, Deng, Jiaqi, Ohore, Okugbe Ebiotubo, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802898/ https://www.ncbi.nlm.nih.gov/pubmed/29415050 http://dx.doi.org/10.1371/journal.pone.0192396

Ejemplares similares

Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study
por: Yang, Chao, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease remission in men through regular exercise
por: Osaka, Takafumi, et al.
Publicado: (2018)

Obesity-Related Genetic Variants and Hyperuricemia Risk in Chinese Men
por: Ma, Zhimin, et al.
Publicado: (2019)

Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population
por: Zheng, Jun, et al.
Publicado: (2023)

Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study
por: Yu, Xiao-Long, et al.
Publicado: (2017)

Triglyceride-Glucose Index is Significantly Associated with the Risk of Hyperuricemia in Patients with Nonalcoholic Fatty Liver Disease
por: Qi, Jiaxin, et al.
Publicado: (2023)

Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects
por: Yang, Zhen, et al.
Publicado: (2016)

Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It
por: Yen, Pei-Chia, et al.
Publicado: (2022)

Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
por: Zhou, Mimi, et al.
Publicado: (2021)

Pilot study: asymptomatic hyperuricemia patients with obesity and nonalcoholic fatty liver disease have increased risk of double contour sign
por: Min, Hong Ki, et al.
Publicado: (2020)

Plasma selenium levels and nonalcoholic fatty liver disease in Chinese adults: a cross-sectional analysis
por: Yang, Zhen, et al.
Publicado: (2016)

Gout in an Obese Patient with Nonalcoholic Steatohepatitis on a Thiazide Diuretic and Association Between Hyperuricemia and Nonalcoholic Steatohepatitis: A Case Report
por: Khan, Zahid, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum
por: Xin, Zhuojun, et al.
Publicado: (2022)

Hyperuricemia remission after colorectal cancer surgery for colorectal cancer patients
por: Liu, Fei, et al.
Publicado: (2023)

Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity
por: Zhou, Xuelian, et al.
Publicado: (2022)

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients
por: Huang, Jee-Fu, et al.
Publicado: (2015)

Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort
por: Yu, Jia, et al.
Publicado: (2021)

Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men
por: Maseroli, E., et al.
Publicado: (2020)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

Women with Metabolic Syndrome and General Obesity Are at a Higher Risk for Significant Hyperuricemia Compared to Men
por: Kim, In Young, et al.
Publicado: (2019)

The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus
por: Zhang, Xingxing, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis
por: Yoshioka, Naoki, et al.
Publicado: (2020)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children
por: Zhang, Jianwei, et al.
Publicado: (2023)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia
por: Zhang, Shujun, et al.
Publicado: (2017)

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Li, Yifang, et al.
Publicado: (2021)

Remnant cholesterol and severity of nonalcoholic fatty liver disease
por: Huang, Hangkai, et al.
Publicado: (2023)

Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
por: Chen, Yifei, et al.
Publicado: (2022)

Sex-Specific Differences in the Association of Metabolically Healthy Obesity With Hyperuricemia and a Network Perspective in Analyzing Factors Related to Hyperuricemia
por: Tian, Simiao, et al.
Publicado: (2020)

Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice
por: Yuan, Youwen, et al.
Publicado: (2022)

Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults
por: Liu, Chang-Qin, et al.
Publicado: (2016)

Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men
por: Yang, Hae Jin, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

Surgical treatment of nonalcoholic fatty liver disease in severely obese patients
por: Vander Naalt, Steven J, et al.
Publicado: (2014)

Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease
por: Park, Ji Sook, et al.
Publicado: (2013)

Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
por: Divella, Rosa, et al.
Publicado: (2019)

Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review
por: Hashem, Anas, et al.
Publicado: (2021)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i7smtf60f0kve82rq2lsi0nepo